Stock Research for attbf

attbf

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

attbf Stock Chart & Research Data

The attbf chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the attbf chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


attbf Due diligence Resources & Stock Charts

The attbf stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View attbf Detailed Price Forecast - CNN Money CNN View attbf Detailed Summary - Google Finance
Yahoo View attbf Detailed Summary - Yahoo! Finance Zacks View attbf Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View attbf Trends & Analysis - Trade-Ideas Barrons View attbf Major Holders - Barrons
NASDAQ View attbf Call Transcripts - NASDAQ Seeking View attbf Breaking News & Analysis - Seeking Alpha
Spotlight View attbf Annual Report - CompanySpotlight.com OTC Report View attbf OTC Short Report - OTCShortReport.com
TradeKing View attbf Fundamentals - TradeKing Charts View attbf SEC Filings - Bar Chart
WSJ View Historical Prices for attbf - The WSJ Morningstar View Performance/Total Return for attbf - Morningstar
MarketWatch View the Analyst Estimates for attbf - MarketWatch CNBC View the Earnings History for attbf - CNBC
StockMarketWatch View the attbf Earnings - StockMarketWatch MacroAxis View attbf Buy or Sell Recommendations - MacroAxis
Bullish View the attbf Bullish Patterns - American Bulls Short Pains View attbf Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View attbf Stock Mentions - StockTwits PennyStocks View attbf Stock Mentions - PennyStockTweets
Twitter View attbf Stock Mentions - Twitter Invest Hub View attbf Investment Forum News - Investor Hub
Yahoo View attbf Stock Mentions - Yahoo! Message Board Seeking Alpha View attbf Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for attbf - SECform4.com Insider Cow View Insider Transactions for attbf - Insider Cow
CNBC View attbf Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for attbf - OTC Markets
Yahoo View Insider Transactions for attbf - Yahoo! Finance NASDAQ View Institutional Holdings for attbf - NASDAQ


Stock Charts

FinViz View attbf Stock Insight & Charts - FinViz.com StockCharts View attbf Investment Charts - StockCharts.com
BarChart View attbf Stock Overview & Charts - BarChart Trading View View attbf User Generated Charts - Trading View




Latest Financial News for attbf


Comfort Launch by Vergence Naturals Exceeds Expectations
Posted on Tuesday December 11, 2018

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort (“Comfort”) through the Company’s wholly-owned subsidiary, Vergence Naturals (“Vergence”), on Cyber-Monday, November 26, 2018. Canada One Communications Inc. (“Canada One”), an Abattis media partner, quotes WorkArea.com in selecting Monday as the best day for e-commerce site sales.


Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018
Posted on Monday December 10, 2018

Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that the Company will be displaying a booth at the O’Cannabiz Conference and Expo taking place at Parq Casino in Vancouver, BC on December 10-11th, 2018 (“O’Cannabiz”). O’Cannabiz will address key cannabis investment themes, emerging opportunities in the developing Canadian market, as well as significant trends and developments in the cannabis industry, from consumers to businesses. The conference will display over 100 global and local cannabis professionals, offering attendees and investors up to date information on what’s next for Canada’s growing cannabis industry.


Abattis Announces Acquisition of Fertilizer Company NutriVida
Posted on Friday December 07, 2018

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that it has signed a non-binding letter of intent dated December 6, 2018 (the “LOI”)  to acquire 100% interest in NutriVida Corp. (“NutriVida”) through an arm’s length transaction, a privately held fertilizer and nutrient company located in Langley, BC. The acquisition of Nurtivida plays directly into the Company’s push to add to its current and future cannabis growth assets, including, but not limited to, its acquisition of Gabriola Green Farms Inc. earlier in 2018. Specifically, the management of NutriVida has been a prominent force in the fertilizer and cultivation industry, with over 35 years of experience and, providing a vast wealth of knowledge and experience in researching, innovating, manufacturing, and selling all-natural, bio-safe, fertilizers and plant nutrients.


Abattis Comments on BCSC Temporary Order
Posted on Tuesday November 27, 2018

Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary order on Monday, November 26, 2018, which centers around share issuances by 11 CSE issuers to a very large group of consultants between February, 2018, and August, 2018.  Abattis has been named as 1 of the 11 issuers as they have ongoing consulting agreements with certain members listed in the group of respondents (the “Respondents”) for services ranging from accounting and finance to marketing.  Also, certain of the Respondents participated in an Abattis private placement for $2.25M.  For these reasons, Abattis has been named as an issuer in this temporary order.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.